This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Soltel - Salmeterol

Cipla (EU) Limited

Description

Long-acting selective beta2 agonist

Reversible airways obstruction in patients requiring long-term regular broncodilator therapy
Nocturnal asthma in patients requiring long-term regular bronchodilator therapy
Prevention of exercise-induced bronchospasm in patients requiring long-term regular bronchodilator therapy
Chronic asthma only in patients who regularly use inhaled corticosteroid (not for immediate relief of acute asthma)
• Child 5–11 years: 50 mcg, twice daily.
• Over 12 years: by inhalation, 50 mcg twice daily. Up to 100 mcg twice daily for more severe airway obstruction.

For COPD
• Adult: 50 mcg, twice daily.

Indications

For the management of reversible airways obstruction (including nocturnal asthma and the prevention of exercise-induced bronchospasm) in patients requiring long-term regular bronchodilator therapy, and COPD.

Preparations Available

Pressurised inhalation

Sizes Available

Pressurised inhalation
Soltel 25 mcg/dose, 120 doses, CFC free 

More on: Bronchodilators , Long-acting selective beta2: agonists